Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'LACHMANN B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. de Anda, GFV; Lachmann, RA; Verbrugge, SJC; Gommers, D; Haitsma, JJ; Lachmann, B
      Partial liquid ventilation improves lung function in ventilation-induced lung injury

      EUROPEAN RESPIRATORY JOURNAL
    2. de Anda, GFV; Lachmann, RA; Gommers, D; Verbrugge, SJ; Haitsma, J; Lachmann, B
      Treatment of ventilation-induced lung injury with exogenous surfactant

      INTENSIVE CARE MEDICINE
    3. de Anda, GFV; Lachmann, B
      Treatment and prevention of acute respiratory failure: Physiological basis

      ARCHIVES OF MEDICAL RESEARCH
    4. Haitsma, JJ; Lachmann, U; Lachmann, B
      Exogenous surfactant as a drug delivery agent

      ADVANCED DRUG DELIVERY REVIEWS
    5. Kaisers, U; Lachmann, B
      Efficacy of specific perfluorocarbons for use in partial liquid ventilation

      CRITICAL CARE MEDICINE
    6. Krause, MF; Orlowska-Volk, M; Hendrik, ER; Gommers, D; Lachmann, B
      A new simple method of staining exogenous surfactant in experimental research

      EUROPEAN RESPIRATORY JOURNAL
    7. Haitsma, JJ; Uhlig, S; Goggel, R; Verbrugge, SJ; Lachmann, U; Lachmann, B
      Ventilator-induced lung injury leads to loss of alveolar and systemic compartmentalization of tumor necrosis factor-alpha

      INTENSIVE CARE MEDICINE
    8. de Anda, GFV; Gommers, D; Verbrugge, SJC; De Jaegere, A; Lachmann, B
      Mechanical ventilation with high positive end-expiratory pressure and small driving pressure amplitude is as effective as high-frequency oscillatory ventilation to preserve the function of exogenous surfactant in lung-lavaged rats

      CRITICAL CARE MEDICINE
    9. Hartog, A; de Anda, GFV; Gommers, D; Kaisers, U; Lachmann, B
      At surfactant deficiency, application of "the open lung concept" prevents protein leakage and attenuates changes in lung mechanics

      CRITICAL CARE MEDICINE
    10. Kunst, PWA; de Anda, GV; Bohm, SH; Faes, TJC; Lachmann, B; Postmus, PE; de Vries, PMJW
      Monitoring of recruitment and derecruitment by electrical impedance tomography in a model of acute lung injury

      CRITICAL CARE MEDICINE
    11. Kunst, PWA; Bohm, SH; de Anda, GV; Amato, MBP; Lachmann, B; Postmus, PE; de Vries, PMJM
      Regional pressure volume curves by electrical impedance tomography in a model of acute lung injury

      CRITICAL CARE MEDICINE
    12. Hartog, A; Gommers, D; Haitsma, JJ; Lachmann, B
      Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure

      BRITISH JOURNAL OF ANAESTHESIA
    13. Haitsma, JJ; Lachmann, B
      Rationale for optimal ventilator settings in transplantation patients

      NEW ASPECTS OF HIGH TECHNOLOLGY IN MEDICINE
    14. Noe, CR; Lachmann, B; Mollenbeck, S; Richter, P
      Determination of reducing sugars in selected beverages by capillary electrophoresis

      ZEITSCHRIFT FUR LEBENSMITTEL-UNTERSUCHUNG UND-FORSCHUNG A-FOOD RESEARCH AND TECHNOLOGY
    15. Hartog, A; Kaisers, U; Gommers, D; Lachmann, B
      Comparing the effects of four different perfluorocarbons on gas exchange and lung mechanics in an animal model of acute lung injury

      ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY
    16. Gommers, D; Hartog, A; Schnabel, R; De Jaegere, A; Lachmann, B
      High-frequency oscillatory ventilation is not superior to conventional mechanical ventilation in surfactant-treated rabbits with lung injury

      EUROPEAN RESPIRATORY JOURNAL
    17. de Anda, GFV; Hartog, A; Verbrugge, SJC; Gommers, D; Lachmann, B
      The Open Lung Concept: pressure controlled ventilation is as effective as high frequency oscillatory ventilation in improving gas exchange and lung mechanics in surfactant-deficient animals

      INTENSIVE CARE MEDICINE
    18. Verbrugge, SJC; de Jong, JW; Keijzer, E; de Anda, GV; Lachmann, B
      Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury

      CRITICAL CARE MEDICINE
    19. Verbrugge, SJC; Gommers, D; Lachmann, B
      Conventional ventilation modes with small pressure amplitudes and high positive end-expiratory pressure levels optimize surfactant therapy

      CRITICAL CARE MEDICINE
    20. Van't Veen, A; Gommers, D; Verbrugge, SJC; Wollmer, P; Mouton, JW; Kooij, PPM; Lachmann, B
      Lung clearance of intratracheally instilled Tc-99m-tobramycin using pulmonary surfactant as vehicle

      BRITISH JOURNAL OF PHARMACOLOGY
    21. Tusman, G; Bohm, SH; de Anda, GFV; do Campo, JL; Lachmann, B
      'Alveolar recruitment strategy' improves arterial oxygenation during general anaesthesia

      BRITISH JOURNAL OF ANAESTHESIA
    22. Hartog, A; de Anda, GFV; Gommers, D; Kaisers, U; Verbrugge, SJC; Schnabel, R; Lachmann, B
      Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation in a model of acute lung injury

      BRITISH JOURNAL OF ANAESTHESIA
    23. Verbrugge, SJC; Uhlig, S; Neggers, SJCMM; Martin, C; Held, HD; Haitsma, JJ; Lachmann, B
      Different ventilation strategies affect lung function but do not increase tumor necrosis factor-alpha and prostacyclin production in lavaged rat lungs in vivo

      ANESTHESIOLOGY
    24. VANTVEEN A; WOLLMER P; NILSSON LE; GOMMERS D; MOUTON JW; KOOIJ PPM; LACHMANN B
      LUNG DISTRIBUTION OF INTRATRACHEALLY INSTILLED TC-99M-TOBRAMYCIN-SURFACTANT MIXTURE IN RATS WITH A KLEBSIELLA-PNEUMONIAE LUNG INFECTION

      ACP. Applied cardiopulmonary pathophysiology
    25. GOMMERS D; VANTVEEN A; VERBRUGGE SJC; LACHMANN B
      COMPARISON OF 8 DIFFERENT SURFACTANT PREPARATIONS ON IMPROVEMENT OF BLOOD-GASES IN LUNG-LAVAGED RATS

      ACP. Applied cardiopulmonary pathophysiology
    26. Verbrugge, SJC; Lachmann, B
      Surfactant replacement therapy in experimental and clinical studies

      ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY
    27. Verbrugge, SJC; Lachmann, B
      Mechanisms of ventilation-induced lung injury and its prevention: Role of surfactant

      ACP-APPLIED CARDIOPULMONARY PATHOPHYSIOLOGY
    28. SO KL; DEBUIJZER E; GOMMERS D; KAISERS U; VANGENDEREN PJJ; LACHMANN B
      SURFACTANT THERAPY RESTORES GAS-EXCHANGE IN LUNG INJURY DUE TO PARAQUAT INTOXICATION IN RATS

      The European respiratory journal
    29. GOMMERS D; EIJKING EP; SO KL; VANTVEEN A; LACHMANN B
      BRONCHOALVEOLAR LAVAGE WITH A DILUTED SURFACTANT SUSPENSION PRIOR TO SURFACTANT INSTILLATION IMPROVES THE EFFECTIVENESS OF SURFACTANT THERAPY IN EXPERIMENTAL ACUTE RESPIRATORY-DISTRESS SYNDROME (ARDS)

      Intensive care medicine
    30. VERBRUGGE SJC; SORUM V; VANTVEEN A; MOUTON JW; GOMMERS D; LACHMANN B
      LUNG OVERINFLATION WITHOUT POSITIVE END-EXPIRATORY PRESSURE PROMOTES BACTEREMIA AFTER EXPERIMENTAL KLEBSIELLA-PNEUMONIAE INOCULATION

      Intensive care medicine
    31. VERBRUGGE SJC; BOHM SH; GOMMERS D; ZIMMERMAN LJI; LACHMANN B
      SURFACTANT IMPAIRMENT AFTER MECHANICAL VENTILATION WITH LARGE ALVEOLAR SURFACE-AREA CHANGES AND EFFECTS OF POSITIVE END-EXPIRATORY PRESSURE

      British Journal of Anaesthesia
    32. VERBRUGGE SJC; DEANDA GV; GOMMERS D; NEGGERS SJCMM; SORM V; BOHM SH; LACHMANN B
      EXOGENOUS SURFACTANT PRESERVES LUNG-FUNCTION AND REDUCES ALVEOLAR EVANS BLUE-DYE INFLUX IN A RAT MODEL OF VENTILATION-INDUCED LUNG INJURY

      Anesthesiology
    33. DEANDA GFV; LACHMANN B
      PROTECTING THE LUNG DURING MECHANICAL VENTILATION WITH THE OPEN LUNG CONCEPT

      Acta anaesthesiologica Scandinavica
    34. Houmes, RJ; Gommers, D; So, KL; Lachmann, B
      Experimental and clinical research to improve ventilation

      APPLIED PHYSIOLOGY IN RESPIRATORY MECHANISMS
    35. LACHMANN B; TENBRINCK R; VANDERZEE H
      ANALGESIC PROPERTIES OF XENON AND NITROUS-OXIDE COMPARED BY TOOTH-PULP EVOKED-POTENTIALS IN PIGS

      ACP. Applied cardiopulmonary pathophysiology
    36. VERBRUGGE SJC; LACHMANN B
      PARTIAL LIQUID VENTILATION

      The European respiratory journal
    37. VERBRUGGE SJC; SORM V; LACHMANN B
      MECHANISMS OF ACUTE RESPIRATORY-DISTRESS SYNDROME - ROLE OF SURFACTANT CHANGES AND MECHANICAL VENTILATION

      Journal of Physiology and Pharmacology
    38. HOUMES RJM; HARTOG A; VERBRUGGE SJC; BOHM S; LACHMANN B
      COMBINING PARTIAL LIQUID VENTILATION WITH NITRIC-OXIDE TO IMPROVE GAS-EXCHANGE IN ACUTE LUNG INJURY

      Intensive care medicine
    39. GOMMERS D; HARTOG A; VANTVEEN A; LACHMANN B
      IMPROVED OXYGENATION BY NITRIC-OXIDE IS ENHANCED BY PRIOR LUNG REAERATION WITH SURFACTANT, RATHER THAN POSITIVE END-EXPIRATORY PRESSURE, INLUNG-LAVAGED RABBITS

      Critical care medicine
    40. VANBLANKENSTEIN JH; SLAGER CJ; SOEI LK; BOERSMA H; STIJNEN T; SCHUURBIERS JCH; KRAMS R; LACHMANN B; VERDOUW PD
      CARDIAC DEPRESSION AFTER EXPERIMENTAL AIR-EMBOLISM IN PIGS - ROLE OF ADDITION OF A SURFACE-ACTIVE AGENT

      Cardiovascular Research
    41. NILSSON K; JOHN J; LACHMANN B; ROBERTSON B; WOLLMER P
      PULMONARY CLEARANCE OF TC-99M-DTPA IN EXPERIMENTAL SURFACTANT DYSFUNCTION TREATED WITH SURFACTANT INSTILLATION

      Acta anaesthesiologica Scandinavica
    42. LACHMANN B; RAJAN NG
      NEW VENTILATORY STRATEGIES IN INTENSIVE-CARE

      Acta anaesthesiologica Scandinavica
    43. KAISERS U; MAX M; SCHNABEL R; BOHM S; HENDRIK ER; ROSSAINT R; LACHMANN B
      PARTIAL LIQUID VENTILATION WITH FC-3280 IN EXPERIMENTAL LUNG INJURY -DOSE-DEPENDENT IMPROVEMENT OF GAS-EXCHANGE AND LUNG-MECHANICS

      ACP. Applied cardiopulmonary pathophysiology
    44. IJSSELSTIJN H; LACHMANN B; GAILLARD JLJ; TIBBOEL D
      EXOGENOUS SURFACTANT IS DISTRIBUTED IN BOTH LUNGS OF NEONATAL RATS WITH CONGENITAL DIAPHRAGMATIC-HERNIA

      ACP. Applied cardiopulmonary pathophysiology
    45. VERBRUGGE SJC; GOMMERS D; BOS JAH; HANSSON C; WOLLMER P; BAKKER WH; LACHMANN B
      PULMONARY TC-99M-HUMAN SERUM-ALBUMIN CLEARANCE AND EFFECTS OF SURFACTANT REPLACEMENT AFTER LUNG LAVAGE IN RABBITS

      Critical care medicine
    46. TUTUNCU AS; HOUMES RJM; BOS JAH; WOLLMER P; LACHMANN B
      EVALUATION OF LUNG-FUNCTION AFTER INTRATRACHEAL PERFLUOROCARBON ADMINISTRATION IN HEALTHY ANIMALS

      Critical care medicine
    47. NOE CR; FREISSMUTH J; ROTHLEY D; LACHMANN B; RICHTER P
      CAPILLARY ZONE ELECTROPHORESIS OF CARBOHY DRATE MIXTURES

      Die Pharmazie
    48. VANTVEEN A; MOUTON JW; GOMMERS D; LACHMANN B
      PULMONARY SURFACTANT AS VEHICLE FOR INTRATRACHEALLY INSTILLED TOBRAMYCIN IN MICE INFECTED WITH KLEBSIELLA-PNEUMONIAE

      British Journal of Pharmacology
    49. VANTVEEN A; GOMMERS D; MOUTON JW; KLUYTMANS JAJW; KRIJT EJ; LACHMANN B
      EXOGENOUS PULMONARY SURFACTANT AS A DRUG DELIVERING AGENT - INFLUENCEOF ANTIBIOTICS ON SURFACTANT ACTIVITY

      British Journal of Pharmacology
    50. TUTUNCU AS; LACHMANN B
      EFFECTS OF PARTIAL LIQUID VENTILATION ON GAS-EXCHANGE AND LUNG-MECHANICS IN HEALTHY ANIMALS

      ACP. Applied cardiopulmonary pathophysiology
    51. TENBRINCK R; SCHEFFERS EC; IJSSELSTIJN H; TIBBOEL D; LACHMANN B
      NITROFEN INDUCED DIAPHRAGMATIC-HERNIA - PRESSURE-VOLUME REGISTRATION AND ARTIFICIAL-VENTILATION IN NEWBORN RATS

      ACP. Applied cardiopulmonary pathophysiology
    52. EIJKING EP; GOMMERS D; SO KL; DEMAAT MPM; LACHMANN B
      A MODEL FOR ACUTE RESPIRATORY-FAILURE INDUCED BY TRACHEAL INSTILLATION OF HOMOLOGOUS PLASMA OR PROTEIN-RICH PULMONARY-EDEMA FLUID

      ACP. Applied cardiopulmonary pathophysiology
    53. GROGONO AW; ALDRETE JA; DASILVA JMC; ERDMANN W; FEISS P; GIUNTA F; HARGASSER S; LACHMANN B; NOVELLI GP; STOKES J; WENDER RH; WINTER R
      PRACTICAL GUIDES FOR THE USE OF LOW-FLOW AND CLOSED-CIRCUIT ANESTHESIA

      ACP. Applied cardiopulmonary pathophysiology
    54. LACHMANN B
      XENON ANESTHESIA - PREREQUISITE FOR ITS USE IN A CLOSED-CIRCUIT SYSTEM

      ACP. Applied cardiopulmonary pathophysiology
    55. FEISS P; LACHMANN B; NOVELLI GP
      LOW-FLOW ANESTHESIA AND MONITORING REQUIREMENTS - DISCUSSION

      ACP. Applied cardiopulmonary pathophysiology
    56. ERDMANN W; ALDRETE JA; GROGONO AW; FEISS P; WENDER RH; HARGASSER S; LACHMANN B; BRACK A
      LOW-FLOW ANESTHESIA AND MONITORING REQUIREMENTS - DISCUSSION

      ACP. Applied cardiopulmonary pathophysiology
    57. ERDMANN W; GROGONO AW; FEISS P; GIUNTA F; STOKES J; LACHMANN B; WENDER RH; BRACK A; NOVELLI GP; HARGASSER S; ALDRETE JA
      LOW-FLOW ANESTHESIA AND MONITORING REQUIREMENTS - DISCUSSION

      ACP. Applied cardiopulmonary pathophysiology
    58. LACHMANN B
      60 YEARS OF SURFACTANT RESEARCH - TELL IT LIKE IT WAS - PREFACE

      ACP. Applied cardiopulmonary pathophysiology
    59. HOUMES RJM; VERBRUGGE SJC; HENDRIK ER; LACHMANN B
      HEMODYNAMIC-EFFECTS OF PARTIAL LIQUID VENTILATION WITH PERFLUOROCARBON IN ACUTE LUNG INJURY

      Intensive care medicine
    60. BRANDSMA AE; TENBRINCK R; IJSSELSTIJN H; SCHEFFERS EC; GAILLARD JLJ; KLUTH D; TENHAVEOPBROEK AAW; LACHMANN B; TIBBOEL D
      CONGENITAL DIAPHRAGMATIC-HERNIA - NEW MODELS, NEW IDEAS

      Pediatric surgery international
    61. VANTVEEN A; MOUTON JW; GOMMERS D; KLUYTMANS JAJW; DEKKERS P; LACHMANN B
      INFLUENCE OF PULMONARY SURFACTANT ON IN-VITRO BACTERICIDAL ACTIVITIESOF AMOXICILLIN, CEFTAZIDIME, AND TOBRAMYCIN

      Antimicrobial agents and chemotherapy
    62. DEJAEGERE A; GOMMERS D; ZIMMERMANN L; HOUMES RJ; SAUER P; LACHMANN B
      HIGH-FREQUENCY VENTILATION (HFV) OF RABBITS WITH 3 TYPES OF VENTILATORS

      Pediatric research
    63. HAFNER D; BEUME R; KILIAN U; KRASZNAI G; LACHMANN B
      DOSE-RESPONSE COMPARISONS OF 5 LUNG SURFACTANT FACTOR (LSF) PREPARATIONS IN AN ANIMAL-MODEL OF ADULT-RESPIRATORY-DISTRESS-SYNDROME (ARDS)

      British Journal of Pharmacology
    64. SCHUTT E; BARBER P; FIELDS T; FLAIM S; HORODNIAK J; KEIPERT P; KINNER R; KORNBRUST L; LEAKAKOS T; PELURA T; WEERS J; HOUMES R; LACHMANN B
      PROPOSED MECHANISM OF PULMONARY GAS TRAPPING (PGT) FOLLOWING INTRAVENOUS PERFLUOROCARBON EMULSION ADMINISTRATION

      Artificial cells, blood substitutes, and immobilization biotechnology
    65. HOUMES RJM; BOS JAH; LACHMANN B
      EFFECT OF DIFFERENT VENTILATOR SETTINGS ON LUNG-MECHANICS - WITH SPECIAL REFERENCE TO THE SURFACTANT SYSTEM

      ACP. Applied cardiopulmonary pathophysiology
    66. LACHMANN B; EIJKING EP; SO KL; GOMMERS D
      IN-VIVO EVALUATION OF THE INHIBITORY CAPACITY OF HUMAN PLASMA ON EXOGENOUS SURFACTANT FUNCTION

      Intensive care medicine
    67. GOMMERS D; HOUMES RJM; LACHMANN B
      EXOGENOUS SURFACTANT AND NITRIC-OXIDE IN EXPERIMENTAL ACUTE RESPIRATORY-FAILURE

      Pediatric research
    68. IJSSELSTIJN H; SCHEFFERS EC; VANMIERT MMALP; LACHMANN B; DEJONGSTE JC; TIBBOEL D; GAILLARD JLJ
      HISTOLOGICAL-FINDINGS IN ARTIFICIALLY VENTILATED NEONATAL RATS WITH CONGENITAL DIAPHRAGMATIC-HERNIA

      Pediatric research
    69. SEGERER H; VANTVEEN A; VANGELDER W; OBLADEN M; LACHMANN B
      EFFECTS OF MULTIPLE SMALL DOSES (MSD) OF EXOGENOUS SURFACTANT (S) VS ONE BOLUS (B) IN SURFACTANT DEFICIENT RABBITS

      Pediatric research
    70. SCHEFFERS EC; IJSSELSTIJN H; TENBRINCK R; LACHMANN B; DEJONGSTE JC; MOLENAAR JC; TIBBOEL D
      EVALUATION OF LUNG-FUNCTION CHANGES BEFORE AND AFTER SURFACTANT APPLICATION DURING ARTIFICIAL-VENTILATION IN NEWBORN RABBITS WITH CONGENITAL DIAPHRAGMATIC-HERNIA

      Journal of pediatric surgery
    71. KESECIOGLU J; TELCI L; ESEN F; AKPIR K; TUTUNCU AS; DENKEL T; ERDMANN W; LACHMANN B
      RESPIRATORY AND HEMODYNAMIC-EFFECTS OF CONVENTIONAL VOLUME CONTROLLEDPEEP VENTILATION, PRESSURE REGULATED VOLUME CONTROLLED VENTILATION AND LOW-FREQUENCY POSITIVE PRESSURE VENTILATION WITH EXTRACORPOREAL CARBON-DIOXIDE REMOVAL IN PIGS WITH ACUTE ARDS

      Acta anaesthesiologica Scandinavica
    72. DENBOER MO; VANWOERKENS LJ; SOMERS JAE; DUNCKER DJ; LACHMANN B; SAXENA PR; VERDOUW PD
      ON THE PRESERVATION AND REGULATION OF VASCULAR TONE IN ARTERIOVENOUS ANASTOMOSES DURING ANESTHESIA

      Journal of applied physiology
    73. LACHMANN B; GOMMERS D
      IS IT RATIONAL TO TREAT PNEUMONIA WITH EXOGENOUS SURFACTANT

      The European respiratory journal
    74. TUTUNCU AS; FAITHFULL NS; LACHMANN B
      INTRATRACHEAL PERFLUOROCARBON ADMINISTRATION COMBINED WITH MECHANICALVENTILATION IN EXPERIMENTAL RESPIRATORY-DISTRESS SYNDROME - DOSE-DEPENDENT IMPROVEMENT OF GAS-EXCHANGE

      Critical care medicine
    75. GOMMERS D; VILSTRUP C; BOS JAH; LARSSON A; WERNER O; HANNAPPEL E; LACHMANN B
      EXOGENOUS SURFACTANT THERAPY INCREASES STATIC LUNG COMPLIANCE, AND CANNOT BE ASSESSED BY MEASUREMENTS OF DYNAMIC COMPLIANCE ALONE

      Critical care medicine
    76. SEGERER H; VANGELDER W; ANGENENT FWM; VANWOERKENS LJPM; CURSTEDT T; OBLADEN M; LACHMANN B
      PULMONARY DISTRIBUTION AND EFFICACY OF EXOGENOUS SURFACTANT IN LUNG-LAVAGED RABBITS ARE INFLUENCED BY THE INSTILLATION TECHNIQUE

      Pediatric research
    77. TUTUNCU AS; AKPIR K; MULDER P; ERDMANN W; LACHMANN B
      INTRATRACHEAL PERFLUOROCARBON ADMINISTRATION AS AN AID IN THE VENTILATORY MANAGEMENT OF RESPIRATORY-DISTRESS SYNDROME

      Anesthesiology
    78. EIJKING EP; GOMMERS D; SO KL; VERGEER M; LACHMANN B
      SURFACTANT TREATMENT OF RESPIRATORY-FAILURE INDUCED BY HYDROCHLORIC-ACID ASPIRATION IN RATS

      Anesthesiology
    79. EIJKING EP; GOMMERS D; SO KL; DEMAAT MPM; MOUTON JW; LACHMANN B
      PREVENTION OF RESPIRATORY-FAILURE AFTER HYDROCHLORIC-ACID ASPIRATION BY INTRATRACHEAL SURFACTANT INSTILLATION IN RATS

      Anesthesia and analgesia
    80. TUTUNCU AS; FAITHFULL NS; LACHMANN B
      COMPARISON OF VENTILATORY SUPPORT WITH INTRATRACHEAL PERFLUOROCARBON ADMINISTRATION AND CONVENTIONAL MECHANICAL VENTILATION IN ANIMALS WITHACUTE RESPIRATORY-FAILURE

      The American review of respiratory disease
    81. SO KL; VANGENDEREN PJJ; GOMMERS D; LACHMANN B
      DIFFERENT SURFACTANT TREATMENT STRATEGIES FOR RESPIRATORY-FAILURE INDUCED BY INTRATRACHEALLY INSTILLED POOLED HUMAN PLASMA IN RATS

      The American review of respiratory disease
    82. LACHMANN B; EIJKING EP; SO KL; GOMMERS D
      INVIVO EVALUATION OF THE INHIBITORY CAPACITY OF HUMAN PLASMA ON EXOGENEOUS SURFACTANT FUNCTION

      The American review of respiratory disease
    83. HOUMES RJM; VOETS MA; VERKAAIK A; ERDMANN W; LACHMANN B
      EFFICACY AND SAFETY OF TRAMADOL VERSUS MORPHINE FOR MODERATE AND SEVERE POSTOPERATIVE PAIN WITH SPECIAL REGARD TO RESPIRATORY DEPRESSION

      Anesthesia and analgesia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 23:23:53